Literature DB >> 2840545

Inhibition of cytochrome c oxidase and hemolysis caused by lysosphingolipids.

H Igisu1, N Hamasaki, A Ito, W Ou.   

Abstract

Galactosylsphingosine, glucosylsphingosine and sphingosine all inhibited cytochrome c oxidase activity in mitochondria from rat liver; more than 50% inhibition was caused by 5 microM lipid (0.1 mumol/mg mitochondrial protein). However, these lysosphingolipids did not suppress the activity of purified cytochrome c oxidase. When the enzyme was "reconstituted" with phosphatidylcholine, the lysosphingolipids clearly inhibited the activity. On the other hand, galactosylsphingosine, glucosylsphingosine and sphingosine all hemolyzed erythrocytes, indicating that lysosphingolipids can disrupt the membrane. Thus, it appears that the inhibition of cytochrome c oxidase, a membrane-bound enzyme in mitochondria, is due to perturbation of the environment of the enzyme and that the primary attacking site of the lysosphingolipids is the membrane. Because the potency to inhibit cytochrome c oxidase and to hemolyze erythrocytes did not differ among these lysosphingolipids and because galactosylceramide caused neither inhibition of cytochrome c oxidase nor hemolysis, the free amino group in the lysosphingolipids seems to be essential to give the effects. In addition, both inhibition of cytochrome c oxidase and hemolysis caused by lysosphingolipids were completely abolished by albumin, suggesting that toxic effects of lysosphingolipids may not be apparent in blood.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2840545     DOI: 10.1007/BF02537346

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.880


  18 in total

1.  PHYSIOLOGICAL ACTIVITY OF PSYCHOSINE.

Authors:  T TAKETOMI; K NISHIMURA
Journal:  Jpn J Exp Med       Date:  1964-10

2.  The isolation of mitochondrial and nuclear mutants of Saccharomyces cerevisiae with specific defects in mitochondrial functions.

Authors:  G Coruzzi; M K Trembath; A Tzagoloff
Journal:  Methods Enzymol       Date:  1979       Impact factor: 1.600

3.  Studies on cytochrome oxidase. Interactions of the cytochrome oxidase protein with phospholipids and cytochrome c.

Authors:  C Yu; L Yu; T E King
Journal:  J Biol Chem       Date:  1975-02-25       Impact factor: 5.157

4.  Sphingomyelin and glucocerebroside of spleen in cases of Gaucher's and Niemann-Pick's diseases.

Authors:  T Taketomi; T Yamakawa
Journal:  Jpn J Exp Med       Date:  1967-10

5.  The subunit composition of mammalian cytochrome c oxidase.

Authors:  P Merle; B Kadenbach
Journal:  Eur J Biochem       Date:  1980-04

6.  Glycolipids of the spinal cord, sciatic nerve, and systemic organs of the twitcher mouse.

Authors:  H Igisu; K Suzuki
Journal:  J Neuropathol Exp Neurol       Date:  1984-01       Impact factor: 3.685

7.  Progressive accumulation of toxic metabolite in a genetic leukodystrophy.

Authors:  H Igisu; K Suzuki
Journal:  Science       Date:  1984-05-18       Impact factor: 47.728

8.  Lipid composition of mitochondria from bovine heart, liver, and kidney.

Authors:  S Fleischer; G Rouser; B Fleischer; A Casu; G Kritchevsky
Journal:  J Lipid Res       Date:  1967-05       Impact factor: 5.922

9.  Analysis of galactosylsphingosine (psychosine) in the brain.

Authors:  H Igisu; K Suzuki
Journal:  J Lipid Res       Date:  1984-09       Impact factor: 5.922

10.  Localization and biosynthesis of NADH-cytochrome b5 reductase, an integral membrane protein, in rat liver cells. I. Distribution of the enzyme activity in microsomes, mitochondria, and golgi complex.

Authors:  N Borgese; J Meldolesi
Journal:  J Cell Biol       Date:  1980-06       Impact factor: 10.539

View more
  18 in total

1.  Binding of galactosylsphingosine (psychosine) by albumin.

Authors:  H Igisu; M Matsuoka; N Hamasaki
Journal:  Lipids       Date:  1990-01       Impact factor: 1.880

Review 2.  Twenty five years of the "psychosine hypothesis": a personal perspective of its history and present status.

Authors:  K Suzuki
Journal:  Neurochem Res       Date:  1998-03       Impact factor: 3.996

3.  Acid ceramidase inhibition ameliorates α-synuclein accumulation upon loss of GBA1 function.

Authors:  Myung Jong Kim; Sohee Jeon; Lena F Burbulla; Dimitri Krainc
Journal:  Hum Mol Genet       Date:  2018-06-01       Impact factor: 6.150

4.  Haemolysis of human erythrocytes by pentachlorophenol and its suppression by albumin.

Authors:  H Igisu
Journal:  Br J Ind Med       Date:  1993-04

5.  Psychosine, the cytotoxic sphingolipid that accumulates in globoid cell leukodystrophy, alters membrane architecture.

Authors:  Jacqueline A Hawkins-Salsbury; Archana R Parameswar; Xuntian Jiang; Paul H Schlesinger; Ernesto Bongarzone; Daniel S Ory; Alexei V Demchenko; Mark S Sands
Journal:  J Lipid Res       Date:  2013-09-04       Impact factor: 5.922

Review 6.  The role of sphingolipids in neuronal development: lessons from models of sphingolipid storage diseases.

Authors:  Rosaria Buccoliero; Jacques Bodennec; Anthony H Futerman
Journal:  Neurochem Res       Date:  2002-08       Impact factor: 3.996

7.  Sphingosine forms channels in membranes that differ greatly from those formed by ceramide.

Authors:  Leah J Siskind; Sharon Fluss; Minh Bui; Marco Colombini
Journal:  J Bioenerg Biomembr       Date:  2005-08       Impact factor: 2.945

8.  Lyso-glycosphingolipids mobilize calcium from brain microsomes via multiple mechanisms.

Authors:  Emyr Lloyd-Evans; Dori Pelled; Christian Riebeling; Anthony H Futerman
Journal:  Biochem J       Date:  2003-11-01       Impact factor: 3.857

9.  Down-regulation of Bcl-2 in the fetal brain of the Gaucher disease mouse model: a possible role in the neuronal loss.

Authors:  Young Bin Hong; Eun Young Kim; Sung-Chul Jung
Journal:  J Hum Genet       Date:  2004-06-04       Impact factor: 3.172

10.  Multiple pathogenic proteins implicated in neuronopathic Gaucher disease mice.

Authors:  You-hai Xu; Kui Xu; Ying Sun; Benjamin Liou; Brian Quinn; Rong-hua Li; Ling Xue; Wujuan Zhang; Kenneth D R Setchell; David Witte; Gregory A Grabowski
Journal:  Hum Mol Genet       Date:  2014-03-05       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.